Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors

BACKGROUND: Management of triple-negative breast cancer (TNBC) is still challenging because of its aggressive clinical behavior and limited targeted treatment options. Cisplatin represents a promising chemotherapeutic compound in neoadjuvant approaches and in the metastatic setting, but its use is l...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Exp Clin Cancer Res
मुख्य लेखकों: Agnello, Lisa, Tortorella, Silvia, d’Argenio, Annachiara, Carbone, Clarissa, Camorani, Simona, Locatelli, Erica, Auletta, Luigi, Sorrentino, Domenico, Fedele, Monica, Zannetti, Antonella, Franchini, Mauro Comes, Cerchia, Laura
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2021
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299618/
https://ncbi.nlm.nih.gov/pubmed/34294133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-02039-w
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन